Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease

Heart

Volumn 98, Issue 19, 2012, Pages 1436-1441

  Sado, Daniel M ^a,b   Flett, Andrew S ^a,b   Banypersad, Sanjay M ^a,b   White, Steven K ^a,b   Maestrini, Viviana ^a   Quarta, Giovanni ^a   Lachmann, Robin H ^c   Murphy, Elaine ^c   Mehta, Atul ^d   Hughes, Derralynn A ^d   McKenna, William J ^a,b   Taylor, Andrew M ^b,e   Hausenloy, Derek J ^a,b   Hawkins, Philip N ^b   Elliott, Perry M ^a,b   Moon, James C ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOTERATE MEGLUMINE;

ADULT; AGED; AORTA STENOSIS; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; EQUILIBRIUM CONTRAST CARDIOVASCULAR MAGNETIC RESONANCE; FABRY DISEASE; FEMALE; HEART AMYLOIDOSIS; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART VOLUME; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL EXTRACELLULAR VOLUME; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; TERTIARY HEALTH CARE; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CONTRAST MEDIA; FEMALE; HEART ATRIA; HEART DISEASES; HEART SEPTUM; HEART VENTRICLES; HUMANS; LONDON; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REFERENCE VALUES; SEX FACTORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84866107331     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302346     Document Type: Article

References (37)

1. Klima M, Burns TR, Chopra A. Myocardial fibrosis in the elderly. Arch Pathol Lab Med 1990;114:938-42.
2. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008;214:199-210. (Pubitemid 351160157)
3. Mewton N, Liu CY, Croisille P, et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011;57:890-903.
4. Pepys MB. Amyloidosis. Annu Rev Med 2006;57:223-41. (Pubitemid 43261989)
5. Lewis J, Mohanty S. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 2010;55:560-78.
6. Araya J, Nishimura S. Fibrogenic reactions in lung disease. Annu Rev Pathol Mech Dis 2010;5:77-98.
7. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004;24:89-97. (Pubitemid 38496051)
8. Nair V, Butany J. Heart transplant biopsies: interpretation and significance. J Clin Pathol 2010;63:12-20.
9. Hawkins PN, Pepys MB. Imaging amyloidosis with radiolabelled SAP. Eur J Nucl Med 1995;22:595-9.
10. Holzmann M, Nicko A, Kuhl U, et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 2008;118:1722-8.
11. Kim RJ, Wu E, Rafael A, et al. The use of contrast enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
12. Arheden H, Saeed M, Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 1999;211:698-708. (Pubitemid 29249466)
13. Jerosch-Herold M, Sheridan DC, Kushner JD, et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;295:H1234-42.
14. Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010;122:138-44.
15. Mestroni L, Maisch B, McKenna WJ, et al. Guidelines for the study of familial dilated cardiomyopathies. Eur Heart J 1999;20:93-102. (Pubitemid 29048080)
16. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008; 29:270-6.
17. Falk RH, Dubrey SW. Amyloid heart disease. N Engl J Med 1997;33:898-909.
18. Dispenzieri A, Gertz MA, Kyle RA, et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 2004;22:3751-7. (Pubitemid 41095215)
19. Sheppard MN, Cane P, Florio R, et al. A detailed examination of heart tissue from three older patients with Anderson-Fabry disease on enzyme replacement therapy. Cardiovasc Pathol 2010;19:293-301.
20. O'Mahony C, Elliott P. Anderson-Fabry disease and the heart. Prog Cardiovasc Dis 2010;52:326-35.
21. Moon JC, Sachdev B, Elkington AG, et al. Gadolinium enhanced CMR in Anderson-Fabry disease: evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003;24:2151-5. (Pubitemid 37486535)
22. Kwak HB, Kim JH, Joshi K, et al. Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart. FASEB J 2011;25:1106-17.
23. Gazotti Debessa CR, Mesiano Maifrino LB, Rodrigues de Souza R. Age related changes of collagen network of the human heart. Mech Aging Devel 2001;122:1049-58. (Pubitemid 32520990)
24. Song Y, Yao Q, Zhu J, et al. Age-related variation in the extracellular tissues of the cardiac conduction system; and autopsy study of 230 Han Chinese. For Sci Int 1999;104:133-42.
25. Olivetti G, Melissari M, Capasso JM, et al. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular Hypertrophy. Circ Res 1991;68:1560-8.
26. Ugander M, Oki AJ, Hsu LY, et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 2012;33:1268-78.
27. Jellis C, Wright J, Kennedy D, et al. Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Circ Cardiovasc Imaging 2011;4:693-702.
28. Jabbour A, Ismail TF, De Noronha SV, et al. Non-invasive assessment of interstitial myocardial fibrosis in pressure-overload left ventricular hypertrophy. J Cardiovasc Magn Reson 2012;14(Suppl 1):O5.
29. Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, et al. Identification of myocardial extracellular matrix expansion by cardiac MRI in hypertensive patients. J Cardiovasc Magn Reson 2011;13(Suppl 1):O109.
30. Barasch E, Gottdiener JS, Aurigemma G, et al. Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study. Circ Heart Fail 2009;2:303-10.
31. Melkko J, Niemi S, Risteki L, et al. Radioimmunoassay of the carboxyterminal propeptide of human type 1 procollagen. Clin Chem 1990;36:1328-32.
32. Hayward CS, Kelly RP, Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 2000;46:28-49. (Pubitemid 30155943)
33. Shaw LJ, Merz CN, Pepine CJ, et al WISE Investigators. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006;47(3 Suppl):4-S20.
34. Regitz-Zagrosek V, Seeland U. Sex and gender differences in myocardial hypertrophy and heart failure. Wien Med Wochenschr 2011;161:109-16.
35. Piechnik SK, Ferreira VM, Dal'Armelina E, et al . Shortened Modified Look-Locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010;12:69.
36. White SK, Sado DM, Flett AS, et al. Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging. Heart 2012;98:773-9.
37. Schelbert EB, Testa SM, Meier CG. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson 2011;13:16.